Concepedia

Ken O’Day

KO

14

Publications

361

Citations

11

H-Index

2010

Active since

Affiliations

Ascendis Pharma (Denmark)(Current)

Cedars-Sinai Medical Center

Biogen (United States)

Astellas Pharma (United States)

Sunovion (United States)

Ken O’Day is an author at Ascendis Pharma (Denmark) specializing in community health sciences, primary care, and health policy.

Top concepts

Publications per year

2010–2020

14

Publications

14

Cost-effectiveness of Coronary CT Angiography versus Myocardial Perfusion SPECT for Evaluation of Patients with Chest Pain and No Known Coronary Artery Disease

James K. Min, Amanda Gilmore, Matthew J. Budoff et al. · Radiology · 2010 · 109 citations

Cost-effectiveness of natalizumab versus fingolimod for the treatment of relapsing multiple sclerosis

Ken O’Day, Kellie Meyer, Ross M. Miller et al. · Journal of Medical Economics · 2011 · 46 citations

Economic and Humanistic Consequences of Preventable Bladder Tumor Recurrences in Nonmuscle Invasive Bladder Cancer Cases

Cheryl T. Lee, Daniel A. Barocas, Denise Globe et al. · The Journal of Urology · 2012 · 34 citations

Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease

James K. Min, Amanda Gilmore, Erica C. Jones et al. · Clinical Imaging · 2017 · 26 citations · Full text

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

Ken O’Day, Krithika Rajagopalan, Kellie Meyer et al. · ClinicoEconomics and Outcomes Research · 2013 · 22 citations · Full text

Rows per page

1–5 of 14